Unstable Angina - Nursing Case Study
Pathophysiology
• Primary mechanism: Unstable angina is primarily caused by the rupture of an atherosclerotic plaque in coronary arteries, leading to platelet aggregation and thrombus formation. This reduces blood flow, causing ischemia without complete occlusion.
• Secondary mechanism: Vasoconstriction exacerbates ischemia. Endothelial dysfunction contributes to reduced nitric oxide production, causing increased vascular tone and further impairing blood supply to the myocardium.
• Key complication: Persistent ischemia increases risk of myocardial infarction and arrhythmias due to prolonged myocardial oxygen deprivation, potentially leading to acute coronary syndrome and cardiac arrest if not promptly addressed.
Patient Profile
Demographics:
68-year-old male, retired construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Chronic Kidney Disease Stage 3, History of Myocardial Infarction, Peripheral Artery Disease
• Current medications: Aspirin 81 mg daily, Metoprolol 50 mg twice daily, Lisinopril 20 mg daily, Metformin 1000 mg twice daily, Atorvastatin 40 mg daily, Clopidogrel 75 mg daily
• Allergies: Penicillin (rash), Shellfish (anaphylaxis)
Current Presentation:
• Chief complaint: Severe chest pain radiating to the left arm and jaw
• Key symptoms: Shortness of breath, diaphoresis, nausea, dizziness, palpitations
• Vital signs: Blood pressure 92/58 mmHg, heart rate 122 bpm, respiratory rate 24 breaths per minute, temperature 37.3°C (99.1°F), oxygen saturation 88% on room air
Section 1
As the patient arrives in the emergency department, the initial assessment reveals significant findings that require immediate attention. Despite the administration of supplemental oxygen via nasal cannula at 4 L/min, the patient's oxygen saturation remains critically low at 90%. The chest pain persists, described as 8/10 on the pain scale, with radiation to the left arm and jaw, accompanied by severe shortness of breath and diaphoresis. Cardiac auscultation reveals an irregular rhythm with tachycardia, while lung sounds are diminished bilaterally, raising concerns for potential pulmonary congestion. The patient is visibly anxious and pale, with cool, clammy skin, indicating inadequate perfusion. An immediate ECG shows ST-segment depression in leads V3-V5, consistent with subendocardial ischemia, but no definitive ST elevation, suggesting ongoing unstable angina rather than a fully evolved myocardial infarction.
In light of these findings, blood tests are expedited, revealing elevated troponin levels at 0.12 ng/mL, indicating myocardial injury, albeit not diagnostic of a full-blown MI at this stage. Renal function tests show a worrisome increase in serum creatinine to 2.1 mg/dL, exacerbating concerns for acute kidney injury secondary to reduced perfusion. Meanwhile, metabolic panels indicate hyperglycemia with a blood glucose level of 278 mg/dL, complicating the management of his diabetes during this acute cardiac event. The patient is transferred to a monitored bed for continuous cardiac monitoring and further stabilization, where intravenous nitroglycerin and beta-blockers are considered to manage the ongoing ischemia and high heart rate.
As the team evaluates the situation, a sudden change in the patient's status demands urgent intervention. The patient experiences an episode of ventricular tachycardia, with a heart rate soaring to 180 bpm, precipitating a rapid deterioration in his hemodynamic status. Blood pressure plummets to 78/42 mmHg, and the patient becomes unresponsive, necessitating immediate advanced cardiac life support protocols. The team prepares for potential defibrillation while considering the possibility of underlying electrolyte imbalances or further myocardial ischemia as contributing factors. This critical juncture underscores the need for swift decision-making and a multidisciplinary approach to stabilize the patient and prevent progression to cardiac arrest.
Section 2
The sudden onset of ventricular tachycardia necessitates immediate intervention. The team initiates advanced cardiac life support (ACLS) protocols, and after assessing the rhythm, they deliver a synchronized cardioversion at 100 joules, successfully restoring the patient's rhythm to sinus tachycardia. However, the patient's blood pressure remains critically low at 82/48 mmHg. Repeat assessment reveals jugular venous distension and persistent bilateral diminished lung sounds, suggesting potential right heart strain or pulmonary edema. Arterial blood gases are drawn, revealing a pH of 7.31, pCO2 of 52 mmHg, and HCO3- of 24 mEq/L, indicating a mixed respiratory and metabolic acidosis, likely due to hypoperfusion and respiratory compromise.
Given the patient's unresponsive state and ongoing hemodynamic instability, the team decides to intubate and mechanically ventilate the patient to optimize oxygenation and ventilation, while simultaneously starting an intravenous norepinephrine infusion to support blood pressure. A stat portable chest X-ray is obtained, showing bilateral pulmonary infiltrates consistent with pulmonary edema, corroborating the clinical suspicion of heart failure exacerbation. The nephrology team is consulted urgently due to the worsening renal function, suspecting acute kidney injury secondary to cardiorenal syndrome. The patient's diabetes further complicates the picture, as fluctuating glucose levels could exacerbate both myocardial and renal stress.
As the patient stabilizes with these interventions, a subsequent echocardiogram is performed, which reveals a reduced ejection fraction of 35%, with global hypokinesis and evidence of right ventricular dysfunction. These findings suggest a significant cardiac impairment, potentially from multi-vessel coronary artery disease, prompting the cardiology team to discuss the urgent need for a coronary angiography to evaluate the extent of the disease and consider revascularization options. This evolving scenario demands keen clinical judgment to prioritize interventions that balance cardiac support, renal protection, and metabolic control, while preparing for potential invasive procedures to mitigate the risk of further cardiac events.
Section 3
As the team continues to manage the patient's complex condition, a sudden change in the patient's status is noted. Despite initial stabilization efforts, the patient begins to exhibit signs of worsening respiratory distress. The mechanical ventilator settings are reassessed, and laboratory results show an increasing lactate level of 5.5 mmol/L, indicating ongoing tissue hypoperfusion. This prompts the team to evaluate the adequacy of current interventions and consider the need for additional support. Meanwhile, the norepinephrine infusion is titrated upwards, yet the patient's blood pressure remains borderline at 90/54 mmHg, underscoring the severity of the hemodynamic compromise.
To further elucidate the underlying pathophysiology, a repeat arterial blood gas analysis is conducted, now revealing a pH of 7.29 with a pCO2 of 55 mmHg and HCO3- of 25 mEq/L, suggesting a worsening respiratory acidosis despite mechanical ventilation. Concurrently, the patient's urine output has significantly decreased to less than 20 mL/hr, raising concerns of impending acute renal failure. The nephrology team recommends initiating continuous renal replacement therapy (CRRT) to manage fluid overload and support renal function, emphasizing the delicate balance required to prevent further cardiovascular decompensation.
The cardiology team, aware of the urgent need for coronary revascularization, prioritizes the scheduling of a coronary angiography. However, they express concern about the patient's current instability, recognizing the risk of further hemodynamic deterioration during the procedure. A multidisciplinary discussion is convened to weigh the benefits and risks of immediate intervention versus further stabilization. This scenario demands advanced clinical judgment to navigate the complex interplay of cardiac, respiratory, and renal challenges, while also considering the timing and approach to potential definitive cardiac interventions.
Section 4
As the multidisciplinary team deliberates on the best course of action, the patient's situation takes a critical turn. New diagnostic results from the coronary angiography reveal a severely stenotic left anterior descending artery, confirming the need for urgent percutaneous coronary intervention (PCI). However, the patient's hemodynamic status continues to be precarious, with blood pressure readings fluctuating between 88/52 mmHg and 92/56 mmHg despite ongoing norepinephrine support. The team's concerns are further compounded by an echocardiogram that shows a left ventricular ejection fraction of 25%, indicating significant myocardial dysfunction.
In light of these findings, the team decides to proceed with a cautious approach to PCI, ensuring that all necessary resuscitative measures are readily available. Meanwhile, the patient's respiratory status continues to worsen, with oxygen saturation dropping to 85% despite FiO2 being increased to 100% on the ventilator. The repeat arterial blood gas reveals a pH of 7.26, pCO2 of 60 mmHg, and HCO3- of 27 mEq/L, signifying a severe respiratory acidosis that necessitates immediate intervention. The critical care team considers the possibility of extracorporeal membrane oxygenation (ECMO) to provide cardiorespiratory support, recognizing the high risks but also the potential to stabilize the patient for PCI.
The nephrology team is closely monitoring the renal function, as urine output remains minimal, and serum creatinine has risen to 3.2 mg/dL. The initiation of continuous renal replacement therapy (CRRT) has begun to help manage fluid overload and minimize metabolic acidosis. The patient's condition demands a delicate balance of aggressive intervention and careful monitoring, with each decision requiring a thorough assessment of potential outcomes and risks. As the team prepares for the next steps, they remain vigilant for any new complications that could arise, understanding that the path to stabilization is fraught with challenges.
Section 5
As the critical care team prepares for the PCI, a sudden change in the patient's status demands immediate attention. The patient's blood pressure drops further to 80/48 mmHg despite maximal norepinephrine support, and the heart rate accelerates to 130 bpm, indicating a compensatory tachycardia. Concurrently, the patient exhibits signs of altered mental status, becoming increasingly lethargic and unresponsive to verbal stimuli. This change raises suspicion of decreased cerebral perfusion as a result of the worsening hemodynamic instability. Rapid bedside assessment reveals cold, clammy extremities and diminished peripheral pulses, highlighting the severity of the patient's shock state.
In response to these alarming developments, the team urgently re-evaluates the priority of interventions. The decision is made to initiate ECMO to provide temporary circulatory support and address the severe hypoxemia, with the hope of stabilizing the patient enough to withstand the PCI. The ECMO circuit is primed, and within minutes of initiation, there is a modest improvement in blood pressure to 95/60 mmHg and oxygen saturation increases to 92%. While these changes are encouraging, they are met with cautious optimism, as the underlying cardiac dysfunction and potential for further complications remain significant.
Amidst the ongoing interventions, a new complication arises: the patient develops an irregular heart rhythm suggestive of atrial fibrillation with rapid ventricular response, confirmed by telemetry. This arrhythmia further complicates the hemodynamic picture, necessitating the addition of an amiodarone infusion to control the rapid rate and restore some degree of rhythm stability. The multidisciplinary team remains on high alert, acutely aware of the precarious nature of the patient's condition and the need for continuous reassessment and adaptation of the treatment plan as they navigate this complex clinical landscape.